196 related articles for article (PubMed ID: 28267202)
1. The role of histidines in amyloid β fibril assembly.
Brännström K; Islam T; Sandblad L; Olofsson A
FEBS Lett; 2017 Apr; 591(8):1167-1175. PubMed ID: 28267202
[TBL] [Abstract][Full Text] [Related]
2. N-terminal domain of myelin basic protein inhibits amyloid beta-protein fibril assembly.
Liao MC; Hoos MD; Aucoin D; Ahmed M; Davis J; Smith SO; Van Nostrand WE
J Biol Chem; 2010 Nov; 285(46):35590-8. PubMed ID: 20807757
[TBL] [Abstract][Full Text] [Related]
3. Pyroglutamate-Modified Amyloid-β(3-42) Shows α-Helical Intermediates before Amyloid Formation.
Dammers C; Reiss K; Gremer L; Lecher J; Ziehm T; Stoldt M; Schwarten M; Willbold D
Biophys J; 2017 Apr; 112(8):1621-1633. PubMed ID: 28445753
[TBL] [Abstract][Full Text] [Related]
4. Common fibrillar spines of amyloid-β and human islet amyloid polypeptide revealed by microelectron diffraction and structure-based inhibitors.
Krotee P; Griner SL; Sawaya MR; Cascio D; Rodriguez JA; Shi D; Philipp S; Murray K; Saelices L; Lee J; Seidler P; Glabe CG; Jiang L; Gonen T; Eisenberg DS
J Biol Chem; 2018 Feb; 293(8):2888-2902. PubMed ID: 29282295
[TBL] [Abstract][Full Text] [Related]
5. Peptide backbone modifications of amyloid β (1-40) impact fibrillation behavior and neuronal toxicity.
Schwarze B; Korn A; Höfling C; Zeitschel U; Krueger M; Roßner S; Huster D
Sci Rep; 2021 Dec; 11(1):23767. PubMed ID: 34887476
[TBL] [Abstract][Full Text] [Related]
6. A mechanistic model to predict effects of cathepsin B and cystatin C on β-amyloid aggregation and degradation.
Perlenfein TJ; Murphy RM
J Biol Chem; 2017 Dec; 292(51):21071-21082. PubMed ID: 29046353
[TBL] [Abstract][Full Text] [Related]
7. A synchrotron-based hydroxyl radical footprinting analysis of amyloid fibrils and prefibrillar intermediates with residue-specific resolution.
Klinger AL; Kiselar J; Ilchenko S; Komatsu H; Chance MR; Axelsen PH
Biochemistry; 2014 Dec; 53(49):7724-34. PubMed ID: 25382225
[TBL] [Abstract][Full Text] [Related]
8. Engineered non-fluorescent Affibody molecules facilitate studies of the amyloid-beta (Aβ) peptide in monomeric form: low pH was found to reduce Aβ/Cu(II) binding affinity.
Lindgren J; Segerfeldt P; Sholts SB; Gräslund A; Karlström AE; Wärmländer SK
J Inorg Biochem; 2013 Mar; 120():18-23. PubMed ID: 23262458
[TBL] [Abstract][Full Text] [Related]
9. Key aromatic/hydrophobic amino acids controlling a cross-amyloid peptide interaction
Bakou M; Hille K; Kracklauer M; Spanopoulou A; Frost CV; Malideli E; Yan LM; Caporale A; Zacharias M; Kapurniotu A
J Biol Chem; 2017 Sep; 292(35):14587-14602. PubMed ID: 28684415
[TBL] [Abstract][Full Text] [Related]
10. Unmodified and pyroglutamylated amyloid β peptides form hypertoxic hetero-oligomers of unique secondary structure.
Goldblatt G; Cilenti L; Matos JO; Lee B; Ciaffone N; Wang QX; Tetard L; Teter K; Tatulian SA
FEBS J; 2017 May; 284(9):1355-1369. PubMed ID: 28294556
[TBL] [Abstract][Full Text] [Related]
11. Direct evidence for self-propagation of different amyloid-β fibril conformations.
Spirig T; Ovchinnikova O; Vagt T; Glockshuber R
Neurodegener Dis; 2014; 14(3):151-9. PubMed ID: 25300967
[TBL] [Abstract][Full Text] [Related]
12. Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system.
Tackenberg C; Kulic L; Nitsch RM
PLoS One; 2020; 15(9):e0239584. PubMed ID: 32966331
[TBL] [Abstract][Full Text] [Related]
13. Iron is a specific cofactor for distinct oxidation- and aggregation-dependent Aβ toxicity mechanisms in a Drosophila model.
Ott S; Dziadulewicz N; Crowther DC
Dis Model Mech; 2015 Jul; 8(7):657-67. PubMed ID: 26035384
[TBL] [Abstract][Full Text] [Related]
14. Evidence that the Human Innate Immune Peptide LL-37 may be a Binding Partner of Amyloid-β and Inhibitor of Fibril Assembly.
De Lorenzi E; Chiari M; Colombo R; Cretich M; Sola L; Vanna R; Gagni P; Bisceglia F; Morasso C; Lin JS; Lee M; McGeer PL; Barron AE
J Alzheimers Dis; 2017; 59(4):1213-1226. PubMed ID: 28731438
[TBL] [Abstract][Full Text] [Related]
15. Aβ-40 Y10F increases βfibrils formation but attenuates the neurotoxicity of amyloid-β peptide.
Dai X; Chang P; Liu W; Xu K; Sun Y; Zhu S; Jiang Z
Int J Mol Sci; 2012; 13(5):5324-5337. PubMed ID: 22754299
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer's beta-amyloid: insights into fibril formation and structure from Congo red binding.
Inouye H; Kirschner DA
Subcell Biochem; 2005; 38():203-24. PubMed ID: 15709480
[TBL] [Abstract][Full Text] [Related]
17. The potential inhibitory effect of β-casein on the aggregation and deposition of Aβ
Hojati S; Ghahghaei A; Lagzian M
J Biomol Struct Dyn; 2018 Jun; 36(8):2118-2130. PubMed ID: 28633568
[TBL] [Abstract][Full Text] [Related]
18. Effect of amino-acid substitutions on Alzheimer's amyloid-beta peptide-glycosaminoglycan interactions.
McLaurin J; Fraser PE
Eur J Biochem; 2000 Nov; 267(21):6353-61. PubMed ID: 11029577
[TBL] [Abstract][Full Text] [Related]
19. AlphaB-crystallin, a small heat-shock protein, prevents the amyloid fibril growth of an amyloid beta-peptide and beta2-microglobulin.
Raman B; Ban T; Sakai M; Pasta SY; Ramakrishna T; Naiki H; Goto Y; Rao ChM
Biochem J; 2005 Dec; 392(Pt 3):573-81. PubMed ID: 16053447
[TBL] [Abstract][Full Text] [Related]
20. Effect of position-specific single-point mutations and biophysical characterization of amyloidogenic peptide fragments identified from lattice corneal dystrophy patients.
Anandalakshmi V; Murugan E; Leng EGT; Ting LW; Chaurasia SS; Yamazaki T; Nagashima T; George BL; Peh GSL; Pervushin K; Lakshminarayanan R; Mehta JS
Biochem J; 2017 May; 474(10):1705-1725. PubMed ID: 28381645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
